Kavar Capital Partners Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
46,963
+369
+0.8% +$81.9K 1.28% 21
2025
Q4
$10.6M Sell
46,594
-50
-0.1% -$11.4K 1.47% 15
2025
Q3
$10.8M Sell
46,644
-201
-0.4% -$40.9K 1.44% 17
2025
Q2
$8.7M Sell
46,845
-374
-0.8% -$69.5K 1.25% 21
2025
Q1
$9.89M Sell
47,219
-25
-0.1% -$4.86K 1.65% 15
2024
Q4
$8.4M Sell
47,244
-193
-0.4% -$35.5K 1.42% 17
2024
Q3
$9.37M Sell
47,437
-491
-1% -$91.6K 1.48% 16
2024
Q2
$8.22M Buy
47,928
+599
+1% +$99.2K 1.48% 16
2024
Q1
$8.62M Sell
47,329
-46,639
-50% -$8.04M 1.59% 14
2023
Q4
$14.6M Buy
93,968
+48,772
+108% +$7.11M 1.63% 14
2023
Q3
$6.74M Sell
45,196
-334
-0.7% -$49K 1.46% 19
2023
Q2
$6.13M Sell
45,530
-210
-0.5% -$30.8K 1.31% 22
2023
Q1
$7.29M Sell
45,740
-52
-0.1% -$7.95K 1.57% 14
2022
Q4
$7.4M Sell
45,792
-566
-1% -$86.8K 1.71% 14
2022
Q3
$6.22M Sell
46,358
-707
-2% -$101K 1.59% 17
2022
Q2
$7.21M Buy
47,065
+264
+0.6% +$40.3K 1.67% 17
2022
Q1
$7.59M Sell
46,801
-1,026
-2% -$149K 1.64% 16
2021
Q4
$6.48M Buy
47,827
+1,304
+3% +$154K 1.35% 21
2021
Q3
$5.02M Buy
46,523
+2,905
+7% +$332K 1.14% 30
2021
Q2
$4.91M Buy
43,618
+911
+2% +$103K 1.19% 29
2021
Q1
$4.62M Buy
42,707
+4,901
+13% +$524K 1.25% 27
2020
Q4
$4.05M Buy
37,806
+676
+2% +$65K 1.17% 27
2020
Q3
$3.25M Buy
37,130
+445
+1% +$41.9K 1.1% 27
2020
Q2
$3.6M Buy
36,685
+849
+2% +$74.8K 1.38% 21
2020
Q1
$2.73M Buy
35,836
+1,020
+3% +$86.9K 1.31% 24
2019
Q4
$3.08M Buy
34,816
+1,050
+3% +$87.2K 1.14% 32
2019
Q3
$2.56M Buy
33,766
+70
+0.2% +$4.8K 1% 35
2019
Q2
$2.45M Buy
33,696
+3,700
+12% +$291K 0.96% 38
2019
Q1
$2.42M Buy
29,996
+3,600
+14% +$295K 1.08% 36
2018
Q4
$2.43M Buy
26,396
+300
+1% +$26.4K 1.31% 26
2018
Q3
$2.47M Buy
26,096
+100
+0.4% +$9.48K 1.22% 34
2018
Q2
$2.41M Sell
25,996
-408
-2% -$39.8K 1.21% 30
2018
Q1
$2.5M Sell
26,404
-1,200
-4% -$132K 1.3% 30
2017
Q4
$2.67M Sell
27,604
-600
-2% -$56.5K 1.42% 31
2017
Q3
$2.51M Hold
28,204
1.37% 27
2017
Q2
$2.04M Sell
28,204
-650
-2% -$43.7K 1.11% 38
2017
Q1
$1.88M Buy
28,854
+633
+2% +$39.8K 1.05% 43
2016
Q4
$1.77M Sell
28,221
-225
-0.8% -$13.7K 1.12% 42
2016
Q3
$1.79M Sell
28,446
-400
-1% -$25.9K 1.16% 36
2016
Q2
$1.79M Sell
28,846
-150
-0.5% -$9.14K 1.15% 35
2016
Q1
$1.66M Sell
28,996
-3,650
-11% -$203K 1.1% 44
2015
Q4
$1.93M Buy
32,646
+825
+3% +$47.5K 1.24% 31
2015
Q3
$1.73M Buy
31,821
+655
+2% +$42.6K 1.22% 28
2015
Q2
$2.09M Buy
31,166
+1,350
+5% +$88.1K 1.42% 13
2015
Q1
$1.75M Buy
29,816
+12,250
+70% +$740K 1.48% 21
2014
Q4
$1.15M Buy
17,566
+300
+2% +$18.9K 0.9% 49
2014
Q3
$997K Buy
17,266
+1,000
+6% +$55.5K 0.85% 54
2014
Q2
$918K Buy
16,266
+185
+1% +$9.71K 0.78% 60
2014
Q1
$826K Buy
16,081
+1,579
+11% +$79.8K 0.68% 61
2013
Q4
$765K Buy
+14,502
New +$713K 0.68% 63

Other funds holding ABBV